Working… Menu

Treatment of Lymphedema: Application of the Kinesio Taping

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00155220
Recruitment Status : Unknown
Verified August 2004 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : September 12, 2005
Last Update Posted : January 27, 2006
Information provided by:
National Taiwan University Hospital

Brief Summary:

There are 2 parts to this study.

First part:

  • Reliability of water displacement, circumference, tonometer.
  • Effect of taping: lifting effect measured with sonography
  • Effect of taping: peripheral circulation measured with DRT4

Second part:

  • Effects of different intervention models including decongestive lymphatic therapy (DLT) and modified DLT

Condition or disease Intervention/treatment Phase
Lymphedema Device: Low Stretch Bandage and Kinesio Tape Phase 2

Detailed Description:

First part:

To investigate the reliability study of water displacement and circumference measurement and the change in thickness of subcutaneous space measured by sonography and blood flow measured by DRT4 in normal subjects after applying K-tape.

Second part:

The incidence of breast carcinoma is in the second place in women in Taiwan. Lymphedema is a common complication after treatment of breast carcinoma; it will lead not only to cosmetic problems but is also uncomfortable, and causes functional limitation for patients. The common management for lymphedema is decongestive lymphatic therapy (DLT) including skin care, manual lymph drainage, remedial exercises and compression therapies. At present, all possible compression therapies for lymphedema have limitations. Patients have poor compliance in using short-stretch bandage and compression garments due to the climate in Taiwan. Applying kinesio tape (K-tape) became a new treatment method in physical therapy; the inventor Dr. Kase claimed that the K-tape can improve circulation and remove congestion. Besides, it demonstrated good therapeutic effects in clinical application. However, there are few studies to show the clinical effects of K-tape. This restricts the further application of K-tape. Following the previous study, the purpose is to compare the effects among traditional DLT, modified DLT which replaces bandage with K-tape, and DLT combined K-tape in patients with lymphedema.

A randomized control study will be executed. Sixty patients with post-mastectomy lymphedema will be randomly grouped into taping, bandage and mixed groups. Each subject will go through 4 weeks of a control period, 4 weeks of an intervention period, and followed by 3 months of an observation period. The evaluation items include physical therapy assessment, the severity of swelling, such as arm circumference, volume of water displacement, related symptoms, the upper extremity function and quality of life. The evaluation will be executed 4 weeks before the interventions (start of control period), before the intervention (start of intervention period), after a 4 week intervention and 3 months after the intervention to compare the effects among 3 kinds of treatment. Subjects in each group will receive treatments including skin care, manual lymphatic drainage, pneumatic compression therapy and exercise during the intervention period; the taping group's patients will receive additional K-tape treatment; the mixed group's patients will receive K-tape combined bandage treatment. Each group will be treated 2 hours/time, 5 times/week; the entire course will take 4 weeks.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Treatment of Lymphedema- Application of the Kinesio Taping
Study Start Date : August 2004
Study Completion Date : March 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lymphedema

Primary Outcome Measures :
  1. The severity of swelling, such as arm circumference, volume of water displacement
  2. The evaluation will be executed 4 weeks before the interventions, before the intervention, after 4 week intervention and 3 months after intervention.

Secondary Outcome Measures :
  1. Related symptoms, the upper extremity function and quality of life
  2. The evaluation time the same as primary outcomes

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   30 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Female breast cancer lymphedema
  2. Unilateral lymphedema
  3. Lymphedema onset 3 months ago
  4. Moderate to severe lymphedema
  5. At least one measurement point greater than 2 cm
  6. Good compliance

Exclusion Criteria:

  1. Port-a-cath on affected side of chest with adhesion
  2. Skin disease
  3. Restriction of active range of motion
  4. Affected upper extremity (UE)
  5. Other diseases or medication might lead to swelling
  6. Irremovable bracelet or ring

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00155220

Layout table for location information
School and Graduate Institute of Physical Therapy College of Medicine, National Taiwan University Recruiting
Taipei, Taiwan
Contact: Jau-Yih Tsauo, PhD    88623123456 ext 7320   
Principal Investigator: Jau-Yih Tsauo, PhD         
Sponsors and Collaborators
National Taiwan University Hospital
Layout table for investigator information
Study Chair: Jau-Yih Tsauo, PhD NTUH
Layout table for additonal information Identifier: NCT00155220    
Other Study ID Numbers: 9261701436
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: January 27, 2006
Last Verified: August 2004
Additional relevant MeSH terms:
Layout table for MeSH terms
Lymphatic Diseases